On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
Every one of us has quoted a healing rate. In clinic, in a grant, in a talk, in a conversation with a patient sitting on the exam table asking the only question that matters: will this close? Most of those quoted numbers came from the control arms of industry trials, which is a bit like... Continue Reading →
Two diabetic foot data engines published the same day on two continents. STEADY (US) is a 5,000-patient, AI-enabled real-world registry; DARE-DiaFoot (Italy) is a deep, multi-instrumental phenotyping protocol that quietly studies remission. One is the census, the other the core sample. Together with EURODIALE, the U.S. Wound Registry, and the National Diabetes Foot Care Audit, they sketch a blueprint for finally measuring what we manage.
This work from our SALSAmiga Ritika Chaturvedi and coworkers is, without question, planting a flag in the ground for precision health and equity. Social, structural and environmental determinants of health, such as food or housing insecurity, systemic racism or chronic stress, account for 60–80% of the modifiable risk of disparities in marginalized populations1,2. Such determinants... Continue Reading →
Important work from the UK's Primary Care Database suggests that the incidence of diabetic foot ulcers, hospitalizations and mortality appears to have reduced over the past decade in people with type 2 diabetes. Aims: A diabetic foot ulcer (DFU) is a severe condition associated with morbidity and mortality. Population-based studies are rare and limited by... Continue Reading →
